[go: up one dir, main page]

TW200744617A - Agent increasing the production of thioredoxin - Google Patents

Agent increasing the production of thioredoxin

Info

Publication number
TW200744617A
TW200744617A TW096108875A TW96108875A TW200744617A TW 200744617 A TW200744617 A TW 200744617A TW 096108875 A TW096108875 A TW 096108875A TW 96108875 A TW96108875 A TW 96108875A TW 200744617 A TW200744617 A TW 200744617A
Authority
TW
Taiwan
Prior art keywords
extract
thioredoxin
present
production
active ingredient
Prior art date
Application number
TW096108875A
Other languages
English (en)
Other versions
TWI406664B (zh
Inventor
Hajime Nakamura
Junji Yodoi
Yuma Hoshino
Original Assignee
Univ Kyoto
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kyoto, Nippon Zoki Pharmaceutical Co filed Critical Univ Kyoto
Publication of TW200744617A publication Critical patent/TW200744617A/zh
Application granted granted Critical
Publication of TWI406664B publication Critical patent/TWI406664B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW096108875A 2006-03-30 2007-03-15 硫氧還蛋白（ｔｈｉｏｒｅｄｏｘｉｎ）產生促進劑 TWI406664B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006093602 2006-03-30

Publications (2)

Publication Number Publication Date
TW200744617A true TW200744617A (en) 2007-12-16
TWI406664B TWI406664B (zh) 2013-09-01

Family

ID=38563498

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096108875A TWI406664B (zh) 2006-03-30 2007-03-15 硫氧還蛋白（ｔｈｉｏｒｅｄｏｘｉｎ）產生促進劑

Country Status (9)

Country Link
US (1) US8338108B2 (zh)
EP (1) EP2011505B1 (zh)
JP (1) JP5043828B2 (zh)
KR (1) KR101400063B1 (zh)
CN (1) CN101410124B (zh)
AU (1) AU2007232971B2 (zh)
CA (1) CA2647968A1 (zh)
TW (1) TWI406664B (zh)
WO (1) WO2007114230A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101732348B (zh) * 2008-11-11 2015-01-14 威世药业（如皋）有限公司 牛痘疫苗致炎兔皮提取物在制备急性脑血管疾病治疗药物中的用途
JP5058962B2 (ja) 2008-12-22 2012-10-24 オリンパス株式会社 細胞画像解析装置、細胞画像解析方法、及びプログラム
WO2011025019A1 (ja) * 2009-08-31 2011-03-03 明治乳業株式会社 チオレドキシン誘導活性を有する乳酸菌ならびにチオレドキシンを介する生体傷害の予防および／または改善用の飲食品および医薬品
KR20110080514A (ko) * 2010-01-06 2011-07-13 엘지이노텍 주식회사 백라이트 유닛 및 이를 이용한 디스플레이 장치
TWI483729B (zh) 2010-03-11 2015-05-11 Nippon Zoki Pharmaceutical Co 慢性前列腺炎、間質性膀胱炎及／或排尿障礙之改善或治療劑
CA2808927C (en) 2010-10-14 2018-10-30 Nippon Zoki Pharmaceutical Co., Ltd. A method for promoting the synthesis of collagen and proteoglycan in chondrocytes
JP5275502B1 (ja) * 2012-10-10 2013-08-28 日本臓器製薬株式会社 抽出物及び製剤
TWI737229B (zh) 2013-04-30 2021-08-21 日商日本臟器製藥股份有限公司 製劑的製造方法、製劑製造的管理方法及製劑的檢查方法
CN107635570B (zh) * 2015-05-29 2019-03-19 日本脏器制药株式会社 多能性干细胞迁移促进剂
CN105663166B (zh) * 2016-03-02 2020-04-17 中国人民解放军疾病预防控制所 特异性抗天花病毒感染模型毒株的生物活性制剂及应用
CN110381966A (zh) * 2017-03-06 2019-10-25 刘军 Aβ-诱导的损伤的抑制或减轻药剂

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53101515A (en) 1977-02-17 1978-09-05 Nippon Zoki Pharmaceutical Co Medicine having anodyne * sedative and antiallergic activity and production thereof
JPS5587724A (en) 1978-12-27 1980-07-02 Nippon Zoki Pharmaceut Co Ltd Selective immune enhancer
JPH0825885B2 (ja) 1988-04-15 1996-03-13 日本臓器製薬株式会社 特発性血小板減少性紫斑病治療剤
JP2539665B2 (ja) 1988-06-20 1996-10-02 日本臓器製薬株式会社 神経疾患治療剤
JP2539669B2 (ja) 1988-07-15 1996-10-02 日本臓器製薬株式会社 糖尿病性神経障害治療剤
JP2594222B2 (ja) 1993-09-28 1997-03-26 日本臓器製薬株式会社 新規生理活性物質−ｋｆ
JP3852786B2 (ja) 1995-04-25 2006-12-06 日本臓器製薬株式会社 骨萎縮改善剤
JP4033936B2 (ja) * 1997-01-08 2008-01-16 日本臓器製薬株式会社 一酸化窒素産生抑制剤
JPH1180005A (ja) * 1997-09-12 1999-03-23 Nippon Zoki Pharmaceut Co Ltd 骨粗鬆症治療剤
JPH11139977A (ja) 1997-11-07 1999-05-25 Nippon Zoki Pharmaceut Co Ltd Ｎｅｆ作用抑制剤
JP2000016942A (ja) 1998-04-27 2000-01-18 Nippon Zoki Pharmaceut Co Ltd 虚血性疾患治療剤
JP2000336034A (ja) 1999-03-19 2000-12-05 Nippon Zoki Pharmaceut Co Ltd ケモカイン産生促進剤
JP2001058949A (ja) * 1999-08-20 2001-03-06 Fujimoto Brothers:Kk 抗ショック剤
JP4612924B2 (ja) * 1999-08-20 2011-01-12 藤本製薬株式会社 サイトカイン調節剤
JP4632480B2 (ja) 2000-05-16 2011-02-16 レドックス・バイオサイエンス株式会社 チオレドキシン誘導物質
US6616515B2 (en) * 2001-09-17 2003-09-09 David L. Dwyer Universal jointing attachment for inserted tooth carbide heads
JP2003336034A (ja) 2002-05-20 2003-11-28 Otsuka Chemical Holdings Co Ltd 非可視領域光遮断材料及び光学フィルター
TW200418498A (en) * 2002-09-30 2004-10-01 Genelabs Tech Inc Nucleoside derivatives for treating hepatitis C virus infection
US7148012B2 (en) * 2002-10-31 2006-12-12 Nippon Zoki Pharmaceutical Co., Ltd. Therapeutic agent for fibromyalgia
JP2004300146A (ja) 2003-03-17 2004-10-28 Nippon Zoki Pharmaceut Co Ltd 感染防御剤
EP1661892B1 (en) * 2003-09-01 2013-07-24 Ono Pharmaceutical Co., Ltd. Condensed ring compound and use thereof
JP2005060408A (ja) 2004-11-30 2005-03-10 Redox Bioscience Inc 慢性閉塞性肺疾患の予防ないし治療剤

Also Published As

Publication number Publication date
CN101410124A (zh) 2009-04-15
KR101400063B1 (ko) 2014-05-26
JPWO2007114230A1 (ja) 2009-08-13
TWI406664B (zh) 2013-09-01
JP5043828B2 (ja) 2012-10-10
EP2011505B1 (en) 2014-12-10
CA2647968A1 (en) 2007-10-11
AU2007232971A1 (en) 2007-10-11
KR20080113409A (ko) 2008-12-30
US20100021431A1 (en) 2010-01-28
EP2011505A1 (en) 2009-01-07
AU2007232971B2 (en) 2013-03-28
US8338108B2 (en) 2012-12-25
CN101410124B (zh) 2013-01-02
EP2011505A4 (en) 2009-12-30
WO2007114230A1 (ja) 2007-10-11

Similar Documents

Publication Publication Date Title
TW200744617A (en) Agent increasing the production of thioredoxin
Santus et al. Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine
WO2011106106A3 (en) Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
UA95105C2 (ru) Применение производного лактамида для снижения токсичности в препарате, который может соприкасаться с кожей или глазами человека или животного, производные лактамида и способы их получения
UA107103C2 (uk) Нікотиновмісні м'які желатинові пастилки
MX2010007295A (es) Composiciones acuosas estables de ciclosporina.
MX2020008616A (es) Rocio de fentanilo sublingual.
WO2008089268A3 (en) Methods and compositions for treating conditions associated with infection and/or inflammation
CL2009001747A1 (es) Composicion farmaceutica que comprende 0,05-0,3% de peroxido de hidrogeno, 0,001-0,03% de eugenol, 0,001-0,01% de alcanfor, 0,001-0,5% de una sal de zinc u otros metales pesados definidos, 1-1,2% de fluoruro de sodio, 2-7% de xilitol y excipientes; metodo de preparacion; uso para prevenir y/o tratar enfermedades orales.
CR11724A (es) Agente para tratar enfermedades
MY160074A (en) Protopanaxadiol-type ginsenoside compositions and uses thereof
MX2012000488A (es) Terapia de combinacion para el tratamiento de la diabetes.
IL192101A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
EA200802223A1 (ru) 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90
NO20064186L (no) Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod
UA104148C2 (ru) [4-(5-аминометил-2-фторфенил)-пиперидин-1-ил]-[7-фтор-1-(2-метоксиэтил)-4-трифторметокси-1h-индол-3-ил]-метанон как ингибитор триптазы тучных клеток
WO2007131232A3 (en) Compositions and their uses directed to ptpr alpha
MX2010000266A (es) Un método para disminuir los síntomas del consumo de alcohol.
MX2009011900A (es) Curacion de herida diabetica.
WO2009028605A1 (ja) 抗がん剤による末梢神経障害の予防又は軽減剤
MX2009005798A (es) Recuperacion de apoplejia.
DOP2011000335A (es) Combinacion antitumoral que comprende ave8062 y sorafenib
AU2012207301A8 (en) Apolipoprotein AIV as an antidiabetic peptide
ES2723778T3 (es) Terapia dirigida a células madre cancerosas y contra cáncer resistente a fármacos
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees